Table 4 Total costs of MS (ICD-10: G 35; 2015–2020 year)

Hospitalisation, €

1 563 398

1 714 724

1 762 691

1 985 472

2 236 369

2 112 815

Pharmacotherapy, €

37 629 952

38 465 909

41 247 081

43 876 949

47 628 108

48 476 067

Diagnostics and special therapeutic/medical procedures, €

2 411 447

2 410 214

2 431 565

2 592 783

2 669 237

2 759 455

Total direct costs, €

41 604 798

42 590 847

45 441 337

48 455 204

52 533 714

53 348 337

Absenteeism (sickness benefits)

1 047 144

1 020 946

1 119 886

1 160 903

1 238 580

1 260 604

Disability (invalidity/long term disability)

596 119

976 385

1 382 586

1 762 157

2 329 906

2 738 582

Total indirect costs^a, €

1 643 263

1 997 331

2 502 472

2 923 060

3 568 486

3 999 186

Total costs of MS, €

43 248 061

44 588 178

47 943 809

51 378 263

56 102 200

57 347 523